Clinical Trials on Hematopoietic System--Cancer in Belgium

Total 6796 results

Jules Bordet Institute
Breast International Group

Completed

BIG Molecular Screening Feasibility Study (BIG MS Pilot)

Metastatic Breast Cancer

Belgium, Spain, Germany, United Kingdom
Universitaire Ziekenhuizen KU Leuven

Recruiting

Lymphoedema and Nocturia/ Nocturnal Polyuria After Pelvic Lymph Node Dissection for Urogenital Cancer (UroLymph)

Urogenital Cancer | Lower Limb Lymphedema

Belgium
European Organisation for Research and Treatment...

Unknown

LungTech: Stereotactic Body Radiotherapy (SBRT) of Inoperable Centrally Located NSCLC (LungTech)

Non-small Cell Lung Cancer Stage I | Non-small Cell Lung Cancer Stage II

Germany, Belgium, United Kingdom, Switzerland
Pfizer

Completed

Phase Ib/II Study of Efficacy and Safety of MEK162 and Panitumumab, in Adult mCRC Patients With Mutant or Wild-type RAS Tumors

Metastatic Colorectal Cancer

Belgium, Canada, France, Spain, United States, Italy, Netherlands
Jessa Hospital

Withdrawn

A Novel Skin Barrier Protectant for Acute Radiodermatitis (CASP-ORL)

Skin Diseases | Head and Neck Cancer | Radiation Toxicity | Radiodermatitis | Radiation Dermatitis

Belgium
European Organisation for Research and Treatment...

Completed

R101933 Combined With Chemotherapy in Treating Patients With Metastatic Breast Cancer That Has Not Responded to Previous Chemotherapy

Breast Cancer

France, Belgium
Eli Lilly and Company

Completed

Multicenter Phase 2 Trial Evaluating Cisplatin-Gemcitabine With Concomitant Thoracic Radiotherapy for Treatment of Inoperable Stage III Non Small Cell Lung Cancer

Non Small Cell Lung Cancer

Belgium
Institut de Recherches Internationales Servier
ADIR, a Servier Group company

Terminated

Phase 3 Study of Futuximab/Modotuximab in Combination With Trifluridine/Tipiracil Versus Trifluridine/Tipiracil Single Agent in Participants With Previously Treated Metastatic Colorectal Cancer (COLSTAR)

Metastatic Colorectal Cancer

Denmark, Japan, Belgium, Finland, Hungary, United States
ADC Therapeutics S.A.

Terminated

Study of ADCT-301 in Patients With Selected Advanced Solid Tumors

Melanoma | Renal Cell Carcinoma | Gastric Cancer | Esophageal Cancer | Ovarian Cancer | Fallopian Tube Cancer | Bladder Cancer | Non-small Cell Lung Cancer | Pancreas Cancer | Colo-rectal Cancer | Triple-negative Breast Cancer | Head and Neck Cancer Squamous Cell Carcinoma

United States, Belgium, United Kingdom
University Hospital, Ghent
Pfizer

Completed

Growth Hormone, IGF-1 and Medical Treatment in Acromegaly: Are There Effects on Gut Hormone Physiology and Postprandial Substrate Metabolism?

Acromegaly

Belgium
Universitaire Ziekenhuizen KU Leuven

Recruiting

Observational Study on Extreme Hypofractionation for Localized Prostate Cancer (OBELIX PCa)

Prostate Cancer | Radiotherapy | SBRT

Belgium
OSE Immunotherapeutics
Servier

Completed

Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of OSE-127 in Healthy Subjects

Healthy Subjects

Belgium
Universitaire Ziekenhuizen KU Leuven

Recruiting

Lymphoedema and Nocturia/Nocturnal Polyuria After Pelvic LND for Urogenital Cancer (UroLymph)

Nocturia | Urogenital Cancer | Lower Limb Lymphedema | Nocturnal Polyuria

Belgium
KU Leuven

Unknown

Serum, Plasma, DNA and Tissue Bank in Chronic Obstructive Pulmonary Disease and Lung Cancer

Chronic Obstructive Pulmonary Disease | Lung Cancer

Belgium
University Hospital, Ghent
Pilipili NV; Imec

Terminated

EEG@HOME (Phase 3b of the Project, Interviews)

Epilepsy

Belgium
University Hospital, Ghent
Pilipili NV; Imec

Completed

EEG@HOME (Phase 2 of the Project, Measurements in Healthy Volunteers)

Epilepsy

Belgium
University Hospital, Ghent
Pilipili NV; Imec

Completed

EEG@HOME (Phase 1 of the Project)

Epilepsy

Belgium
Universitaire Ziekenhuizen KU Leuven

Recruiting

Brain Activity in Epilepsy

Epilepsy

Belgium
University Ghent

Completed

TMS as a Tool for the Evaluation of Neuromodulatory Effects of Transcutaneous Vagus Nerve Stimulation

Epilepsy

Belgium
European Organisation for Research and Treatment...

Completed

Pazopanib Hydrochloride, Paclitaxel, and Carboplatin in Treating Patients With Refractory or Resistant Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity Cancer

Belgium, Netherlands, Spain
Universitair Ziekenhuis Brussel

Recruiting

Evaluation of 68-GaNOTA-Anti-HER2 VHH1 Uptake in Brain Metastasis of Cancer Patients

Carcinoma | Receptor, ErbB-2

Belgium
DeuterOncology

Recruiting

Study to Determine the Safety and Pharmacokinetics of DO-2 in Patients With Advanced or Refractory Solid Tumours

Adult Solid Tumor | Lung Cancer | Advanced Solid Tumor | Non-small Cell Lung Cancer | Non-small Cell Carcinoma | Refractory Tumor | Hereditary Renal Papillary Cancer

France, Belgium, Netherlands
Hasselt University

Completed

Walk With Me: a Mobile Application to Improve Walking in Persons With MS

Multiple Sclerosis

Belgium
General Hospital Groeninge

Completed

Single-centre Propensity Score-matched Comparison of Laparoscopic Versus Open Pancreatoduodenectomy (PSMLOPD)

Pancreatic Neoplasms

Belgium
Erasme University Hospital
European Society of Intensive Care Medicine

Completed

TRansfusion Strategies in Acute Brain INjured Patients (TRAIN)

Blood Transfusion | Acute Brain Injury

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Treatment of Difficult to Control Focal Epilepsy With Repetitive Transcranial Magnetic Stimulation (rTMS)

Epilepsies, Partial

Belgium
KU Leuven

Active, not recruiting

Add-on Clioquinol in Drug-resistant Childhood Epilepsy: an Exploratory Study (CLIOKID)

Epilepsy Intractable

Belgium
Myles Mc Laughlin

Completed

Interphase Gap in Biphasic Stimulation in DBS for ET

Essential Tremor

Belgium
Cliniques universitaires Saint-Luc- Université...

Completed

Influence of Respiratory Gases Conditioning on Aerosol Delivery During Invasive Ventilation (Aerovent-)

Brain Injuries, Traumatic

Belgium
Universitair Ziekenhuis Brussel
Brugmann University Hospital

Recruiting

Longitudinal Neurocognitive, Psychosocial and Health-related Quality of Life Assessment in Advanced Cancer Survivors Treated With Immunotherapy and the Efficacy of Integrative Neurocognitive Remediation Therapy (CognIT)

Quality of Life | Cognitive Dysfunction | Psychological Distress | Immunotherapy | Cognitive Behavioral Therapy | Cancer Survivors | Cognitive Remediation | Neuropsychology | Psycho-Oncology

Belgium
European Organisation for Research and Treatment...

Completed

Lonafarnib, Trastuzumab, and Paclitaxel in Treating Patients With HER2/Neu-Overexpressing Stage IIIB, Stage IIIC, or Stage IV Breast Cancer

Breast Cancer

Belgium, Netherlands, France
Hasselt University
Revalidatie & MS Centrum Overpelt; National MS Center Melsbroek

Recruiting

Fatigability in Persons With Multiple Sclerosis: Inputs From Cognition, Walking and Coordination

Multiple Sclerosis

Belgium
Francis Corazza

Recruiting

Prognostic Value of Cerebrospinal Fluid Immunoglobulin Free Light Chains in Patients With Multiple Sclerosis

Multiple Sclerosis

Belgium
University Ghent
University Hospital, Ghent

Completed

Measuring Motor Imagery Ability in Patients With Traumatic Brain Injury.

Healthy | Traumatic Brain Injury

Belgium
Brugmann University Hospital

Completed

Use of the Nine Holes Peg Test in Multiple Sclerosis: Participation of Elementary Neurological Components in the Functional Evaluation of Manual Dexterity

Multiple Sclerosis

Belgium
Sanofi
Regeneron Pharmaceuticals

Completed

A Study to Evaluate the Effects of Aflibercept on QTc Interval in Cancer Patients (QUTIE)

Cancer

United States, Romania, Germany, Italy, Turkey, Belgium, Denmark
Université Catholique de Louvain

Completed

Effect of Adaptive Sports After Acquired Physical Disability

Spinal Cord Injuries | Sports Physical Therapy

Belgium
Jules Bordet Institute

Completed

Preoperative Chemosensitivity Testing to Predict Treatment Benefit in Adjuvant Stage III Colon Cancer (PePiTA)

Colon Cancer

Belgium
Cliniques universitaires Saint-Luc- Université...

Recruiting

Epileptogenic Network Visualisation With Advanced MRI (EPIVAM)

Drug Resistant Epilepsy

Belgium
Hasselt University

Completed

Art for MS - Controlled Trial

Multiple Sclerosis | Fatigue

Belgium
Universitaire Ziekenhuizen KU Leuven
Pfizer

Completed

SU11248 as Consolidation After Response to Taxanes in Metastatic Breast Cancer

Metastatic Breast Cancer

Belgium
AstraZeneca

Completed

Faslodex Registry: Fulvestrant in Current Clinical Practice

Metastatic Breast Cancer

Belgium
Universitaire Ziekenhuizen KU Leuven

Recruiting

Local Ablative Therapy for Patients With Multiple (4-10) Brain Metastases (LAT-MUM)

Brain Metastases, Adult

Belgium
Hasselt University
Tel Aviv University; Sheba Medical Center; Centre Hospitalier Universitaire de... and other collaborators

Completed

Cognitive-motor Interference in Persons With MS

Multiple Sclerosis

Belgium
Frédéric A. Houssiau, MD, PhD

Unknown

RING - Rituximab for Lupus Nephritis With Remission as a Goal (RING)

Lupus Nephritis

Belgium
Frédéric A. Houssiau, MD, PhD

Completed

Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy of Lupus Nephritis. (MAINTAIN)

Lupus Nephritis

Belgium
Belgian Gynaecological Oncology Group

Completed

Weekly Paclitaxel/Carboplatin With Neupogen in Gynaecological Cancers

Ovarian Cancer | Endometrial Cancer | Uterine Cervical Cancer

Belgium
University Hospital, Ghent

Terminated

Continuous Thetaburst Stimulation for the Treatment of Refractory Epilepsy - Safety, Feasibility and Proof-of-concept

Epilepsies, Partial

Belgium
LivaNova

Withdrawn

XLTCS - Accelerometer Data Collection in an Epilepsy Monitoring Unit (EMU) (XLTCS)

Epilepsy, Tonic-Clonic

Belgium
Eli Lilly and Company

Terminated

A Study to Treat Small Cell Lung Cancer With a Combination of Cisplatin, Pemetrexed, and Radiotherapy

Small Cell Lung Cancer | SCLC | Carcinoma, Small Cell

Netherlands, Belgium

Clinical Trials on Hematopoietic System--Cancer in Belgium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hong Kong

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations